The pill formulation of zanubrutinib (Brukinsa; BeOne) has become accredited for all 5 indications throughout a number of hematological cancers.Blood clots and encephalitis have also been described, and Regardless of no scenarios currently being documented as of yet, You can find a potential chance of blood cancer, spurring authorities to recommend